A full conference programme is now available online click the days below to view the relevant information. The conference programme has been awarded 14 CPD points by the Royal College of Pathologists.
Infection Prevention 2013 features a number of streams and concurrent study days. Posters have been developed to promote these streams and are below for you to download and display within your hospital / organisation. To download these posters please click on the links below:
If you have any trouble downloading or printing these please contact firstname.lastname@example.org
To download the application forms and programme for the Care Homes, Dental, Perioperative and GP conferences please click on the links below:
At Infection Prevention 2013 there are four company symposia which are in addition to the main conference programme, we would urge you to attend these sessions:
• Ethicon Biopatch Company Symposium, Monday 30th September, 12.30 – 13.00, Breakout Room
Title: Infection Prevention: Focus on What Really Works
Speaker: Dr Duncan Wyncoll, Consultant Intensivist from Guy’s and St Thomas’ NHS Foundation Trust
Details: The rate of catheter-related blood stream infections (CR-BSI) has reduced significantly over the last decade with the adoption of bundled interventions leading some authors to suggest that CR-BSI should now be totally preventable. Early removal of unused lines and a high-index of suspicion for infection are vital, but an increasing data also suggests that chlorhexidine impregnated discs placed at line-entry sites, coupled with daily bathing using chlorhexidine washcloths may be two of the most evidenced-based prevention strategies.
• Deb Company Symposium, Tuesday 1st October, 13.10 – 13.40, Breakout Room
Program Title: Enhancing Hospital Safety Culture - Achieving Reliable Measurement of Hand Hygiene Compliance
Speaker: Paul Alper, Vice President, Strategy and Business Development, Deb Worldwide Healthcare
Learning Objectives - attendees will:
1. Be aware of recent scientific, clinical and economic rationale for improving hand hygiene
2. Understand the typical way hand hygiene is monitored and the evidence that says it should no longer be the "standard"
3. Be able to describe the essential elements of a multi modal improvement model for hand hygiene compliance
4. Understand how electronic monitoring systems can work and provide a better way to give performance feedback and drive improvement
5. Know what to look for when evaluating electronic hand hygiene monitoring systems
Who should attend: Infection Prevention, Patient Safety and Healthcare Quality Professionals & Senior hospital leaders interested in improving overall quality and patient safety by reducing preventable infections and with that, their associated financial impact.
• PDI Company Symposium, Wednesday 2nd October, 8.00 – 8.30, Platinum 1
Title: Wipe it out , one chance to get it right
Speaker: Peter Hoffman - Consultant Clinical Scientist, Laboratory of healthcare-associated Infection, Centre for infections, Health Protection Agency
Details: Pre-prepared disinfectant wipes are a common component of infection prevention, however there is no globally accepted method to validate their efficacy. This presentation will review how users can approach an assessment of tests that may be used and whether these are, or are not, capable of predicting how that wipe will perform. It will also examine how claims of sporicidal activity, particularly those against Clostridium difficile, may be supported and review some relevant publications.
• Public Health England Symposium, Wednesday 2nd October, 13.00 – 13.30, Breakout Room
Title: ‘Polyclonal antibodies - applications in the prevention and treatment of Clostridum difficile infection'
Speakers: Dr Cliff Shone (Scientific Leader) and Dr. S.S. Vasan (Senior Business Development Manager - Research & Innovation), Public Health England, Porton Down SP4 0JG
1. Learn why antibiotics, monoclonal antibodies, etc. are less effective against severe forms of CDI
2. Understand how Public Health England scientists are overcoming this problem by developing cheaper polyclonal antibodies that can quickly neutalise diverse toxinotypes with the potential to offer clinical benefits
3. Find out how to participate in our Phase 1 and 2a trials.
To help plan your journey download the free ExCeL London App today: